Impact of Ukraine Invasion Limited in Japan? Trader Group Says Epirubicin Is Only API Possibly Affected

February 25, 2022
Ichiro Fujikawa, Chairman, Japan Pharmaceutical Traders’ Association The impact of Russia’s Ukraine invasion on the Japanese pharma industry appears to be limited for now, with epirubicin, a cancer drug, being the only API imported from Ukraine according to Japanese regulators’...read more